Company page

Artelo Biosciences, Inc.

Artelo Biosciences, Inc. is a public company traded under the ticker ARTL in the American market. With a market capitalization of approximately $4.39 million, the company focuses on developing innovative therapies to address unmet medical needs. Artelo is committed to advancing its research and development efforts in the biopharmaceutical sector.